TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
TEVA PHARMACEUTICAL INDUSTRIES LTD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$41.31−0.19 (-0.46%)
Close on Oct 19, 2026
- Market cap
- $48.13B
- P/E (TTM)
- 68.9
- Dividend yield
- –
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
–
Consecutive increases
0 years
Not raised last year
Five-year growth
–
Per year, per share
Payout ratio, FY2025
–
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | – | – | – | – |
| FY2024 | – | – | – | – |
| FY2023 | – | – | – | – |
| FY2022 | – | – | – | – |
| FY2021 | – | – | – | – |
| FY2020 | – | – | – | – |
| FY2019 | $0.00 | – | – | – |
| FY2018 | $0.00 | -100.0% | $12.00M | -0.6% |
| FY2017 | $0.85 | -37.5% | $901.00M | -5.5% |
| FY2016 | $1.36 | 0.0% | $1.30B | 396.0% |
| FY2015 | $1.36 | +1.5% | $1.16B | 72.7% |
| FY2014 | $1.34 | +4.7% | $1.16B | 37.8% |
| FY2013 | $1.28 | +24.3% | $1.09B | 85.8% |
| FY2012 | $1.03 | +15.7% | $855.00M | 43.6% |
| FY2011 | $0.89 | +20.3% | $800.00M | 29.0% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.